Clinical Trial Update: A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/3 clinical trial is evaluating BHV-8000 for efficacy, safety, and tolerability in adults with early Parkinson disease; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BHV-8000

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: RECRUITING